Argomenti e Notizie
con raccolte
bibliografiche su
PubMed Logo
a cura del
Dott. C.Tarozzi
Anno 19°
Num. 123
Recens. 2376
Aderiamo allo standard HONcode per l'affidabilità dell'informazione medica questo sito aderisce fin dal 2004 allo standard HONcode per l'affidabilità dell'informazione medica. Verifica qui.
Rassegna - Alimenti e Calcio - Questionari - T-Score - Valore di un Test - Calcolatori - Contatti - Digitalia - Radioactivity
Ricerca nell'archivio di questo sito...
Nuova bibliografia selezionata fino al mese di settembre 2014 (recensioni 19) Ordina per Autore - Titolo - Rivista
Tonogai I, Goto T, Hamada D, Iwame T, Yoshioka S, Tsutsui T, Goda Y, Egawa H, Sairyo K.
Bilateral atypical femoral fractures in a patient with multiple myeloma treated with intravenous bisphosphonate therapy.
Case Rep Orthop. 2014;2014:452418.

Wolin EA, Banks KP, Vroman PJ.
Bisphosphonate-Associated Atypical Subtrochanteric Femur Fracture.
J Nucl Med Technol. 2014 Aug 14.

Reginster JY.
Cardiac concerns associated with strontium ranelate.
Expert Opin Drug Saf. 2014 Sep;13(9):1209-13.

Paggiosi MA, Peel N, McCloskey E, Walsh JS, Eastell R.
Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study.
Osteoporos Int. 2014 Jul 30. [Epub ahead of print]

Niimi R, Kono T, Nishihara A, Hasegawa M, Matsumine A, Kono T, Sudo A.
Cortical Thickness of the Femur and Long-term Bisphosphonate Use.
J Bone Miner Res. 2014 Aug 22.

Poole KE, Treece GM, Gee AH, Brown JP, McClung MR, Wang A, Libanati C.
Denosumab Rapidly Increases Cortical Bone in Key Locations of the Femur: A 3D Bone Mapping Study in Women with Osteoporosis.
J Bone Miner Res. 2014 Aug 4.

O'Halloran M, Boyd N, Smith A.
Denosumab and osteonecrosis of the jaws - the pharmacology, pathogenesis and a report of two cases.
Aust Dent J. 2014 Aug 16.

Hue TF, Cummings SR, Cauley JA, Bauer DC, Ensrud KE, Barrett-Connor E, Black DM.
Effect of Bisphosphonate Use on Risk of Postmenopausal Breast Cancer: Results From the Randomized Clinical Trials of Alendronate and Zoledronic Acid. JAMA
Intern Med. 2014 Aug 11.

Bouvet A, Sabatier B, Savoldelli V, Caruba T, Pouchot J.
Evaluation of the prescription of osteoporosis treatment after a major osteoporotic fracture.
J Clin Rheumatol. 2014 Sep;20(6):347-8.

Blake GM, Siddique M, Frost ML, Moore AE, Fogelman I.
Imaging of Site Specific Bone Turnover in Osteoporosis Using Positron Emission Tomography.
Curr Osteoporos Rep. 2014 Aug 29. [Epub ahead of print]

Watts NB.
Long-term risks of bisphosphonate therapy.
Arq Bras Endocrinol Metabol. 2014 Jul;58(5):523-9.

Pimentel L, Portela S, Loureiro A, Bandeira F.
Normocalcemic primary hyperparathyroidism: long-term follow-up associated with multiple adenomas.
Arq Bras Endocrinol Metabol. 2014 Jul;58(5):583-6.

Strong AL, Ohlstein JF, Jiang Q, Zhang Q, Zheng S, Boue SM, Elliott S, Gimble JM, Burow ME, Wang G, Bunnell BA.
Novel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent mechanisms.
Stem Cell Res Ther. 2014 Aug 28;5(4):105. [Epub ahead of print]

Wu FJ, Sheu SY, Lin HC.
Osteoporosis is associated with antiepileptic drugs: a population-based study.
Epileptic Disord. 2014 Aug 28. [Epub ahead of print]

Lima GA, Paranhos Neto Fde P, Pereira GR, Gomes CP, Farias ML.
Osteoporosis management in patient with renal function impairment.
Arq Bras Endocrinol Metabol. 2014 Jul;58(5):530-9.

Lambrelli D, Burge R, Raluy-Callado M, Chen SY, Wu N, Schoenfeld MJ.
Retrospective database study to assess the economic impact of hip fracture in the United Kingdom.
J Med Econ. 2014 Aug 28:1-31. [Epub ahead of print]

Chen W, Melamed ML, Abramowitz MK.
Serum Bicarbonate and Bone Mineral Density in US Adults.
Am J Kidney Dis. 2014 Aug 26.

Silverman SL, Komm BS, Mirkin S.
Use of FRAX(®)-based fracture risk assessments to identify patients who will benefit from osteoporosis therapy.
Maturitas. 2014 Jul 16.

Reginster JY, Neuprez A, Lecart MP, Sarlet N, Distèche S, Bruyère O.
[Treatment of post-menopausic osteoporosis: what's new in 2014?].
Rev Med Liege. 2014 Jul-Aug;69(7-8):441-53. French.

Interessantissimo articolo all' American Society for Bone and Mineral Research (ASBMR) 2014 annual meeting.
Bisphosphonate Drug Holiday Doesn't Increase Fracture Risk (click per scaricare il file PDF)
(Vers. 2.1)  Modificato il 30-8-2014   
questo sito aderisce ai principi HONCODE    disclaimer